- 收听数
- 0
- 性别
- 保密
- 听众数
- 84
- 最后登录
- 2025-5-11
- QQ
 - UID
- 4209
- 阅读权限
- 40
- 帖子
- 6378
- 精华
- 0
- 在线时间
- 6013 小时
- 注册时间
- 2013-6-1

- 科研币
- 69
- 速递币
- 7481
- 娱乐币
- 11075
- 文献值
- 387
- 资源值
- 400
- 贡献值
- 40
|
10速递币
| 题名 | In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellualr carcimona, with better tolerance and similar survival. | | 链接 | http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=2&atlKy=12341&isuKy=1168&isArt=t |
|
|